Transaction · 0001601830-26-000120

Borgeson Blake

Borgeson Blake, DIR, reported an open-market or private sale at RECURSION PHARMACEUTICALS, INC. involving 50000.000000 shares for an estimated $242000.00. Reported holdings after the transaction were 6108287.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SDIR
RXRXRECURSION PHARMACEUTICALS, INC.
Filing timeOct 07
Trade dateOct 06, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position traded0.81%Shares sold ÷ (holdings after + shares sold). Estimated position before: 6,158,287 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$4.26
Pre-filing
1mo ago -14.8%1w ago -5.4%1d ago +12.2%
Returns since
7d30d90d180d1y

RXRX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
RXRX since 2026-10-07Filed 2 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001601830-26-000120
Class A Common Stock
Transaction date
Oct 06, 2026
Filed Oct 07, 2026, 10:08 PM · 1d delay
Shares
50.0k sh
$4.84 per share
Estimated value
-$242k
Computed from shares × price
Holdings after
6.10M sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling Direct Ownership 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2025.

  2. F2

    This transaction was executed in multiple trades at prices ranging from $4.80 to $5.00. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide up…

Original filing · 0001601830-26-000120
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

RXRX